Eli Lilly and Company News Releases

Taltz® Delivers More Cumulative Days with Completely Clear Skin for Adults with Psoriasis Compared to Seven Other Biologics in Novel Network Meta-Analysis

- Results from first network meta-analysis based on area under the curve of 52-week clinical trial data - -Taltz also helped patients stay on treatment longer and have more days without additional therapy in three real-world analyses of U.S. claims data - INDIANAPOLIS , April 23, 2021 /PRNewswire/
favicon
investor.lilly.com
investor.lilly.com